Literature DB >> 22933068

Experimental use of mouse models of systemic lupus erythematosus.

Stanford L Peng1.   

Abstract

Mouse models of lupus have for many years provided accessible and reliable research systems for the pathogenesis and therapy of systemic autoimmune disease, spanning a spectrum of inbred strains that develop spontaneous disease to experimentally induced, sometimes genetically manipulated animals. Nearly all the models share in common the development of glomerulonephritis and autoantibodies, including antinuclear and DNA specificities, the most common endpoints examined in experimental studies, but exhibit specific differences in the incidence of other end-organ manifestations such as hemolytic anemia, arthritis, dermatitis, and vasculitis. This chapter contrasts the clinical characteristics of these various models, providing an outline for their use and analysis.

Entities:  

Mesh:

Year:  2012        PMID: 22933068     DOI: 10.1007/978-1-60761-720-4_7

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

1.  T cells from induced and spontaneous models of SLE recognize a common T cell epitope on β2-glycoprotein I.

Authors:  David Salem; Rebecca Subang; Masataka Kuwana; Jerrold S Levine; Joyce Rauch
Journal:  Cell Mol Immunol       Date:  2018-03-23       Impact factor: 11.530

Review 2.  Mesenchymal stem cells in the treatment of inflammatory and autoimmune diseases in experimental animal models.

Authors:  Matthew W Klinker; Cheng-Hong Wei
Journal:  World J Stem Cells       Date:  2015-04-26       Impact factor: 5.326

3.  Repeated administration of alpha-galactosylceramide ameliorates experimental lupus nephritis in mice.

Authors:  Takahiro Uchida; Hiroyuki Nakashima; Akira Yamagata; Seigo Ito; Takuya Ishikiriyama; Masahiro Nakashima; Shuhji Seki; Hiroo Kumagai; Naoki Oshima
Journal:  Sci Rep       Date:  2018-05-29       Impact factor: 4.379

Review 4.  Application of Mesenchymal Stem Cells in Inflammatory and Fibrotic Diseases.

Authors:  Jae-Sung Ryu; Eun-Jeong Jeong; Jong-Yeup Kim; Soon Ju Park; Won Seok Ju; Chang-Hyun Kim; Jang-Seong Kim; Young-Kug Choo
Journal:  Int J Mol Sci       Date:  2020-11-07       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.